Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-Ab™
Target-Humanized Mouse Models (HUGO-GT™)
Target-Humanized Mouse Models (CDS)
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Custom Model Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Preclinical Solutions
Antibody Discovery Platform
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Neuropathic Pain
Metabolic
Obesity
MASH & MASLD
Cardiovascular
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Retinal-related diseases
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Systemic Lupus Erythematosus
Drug Classification
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
iCyagen
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Company Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeResource RepositoryEngineering an isogenic APP Swedish human iPSC-derived cortical neuron model of Familial Alzheimer’s disease that recapitulates hallmark amyloid and tau pathologies
Poster

Engineering an isogenic APP Swedish human iPSC-derived cortical neuron model of Familial Alzheimer’s disease that recapitulates hallmark amyloid and tau pathologies

Describing an isogenic human iPSC-derived cortical neuron model of familial Alzheimer’s disease, created by introducing the APP Swedish (K670N/M671L) mutation into healthy-donor PBMC-derived iPSCs, with matched parental WT controls and validated amyloid and phospho-tau phenotypes.
Engineering an isogenic APP Swedish human iPSC-derived cortical neuron model of  Familial Alzheimer’s disease that recapitulates hallmark amyloid and tau pathologies

Overview

Comparisons between unrelated iPSC donor lines are confounded by genetic background, limiting their value for modeling Alzheimer’s disease. We reprogrammed healthy-donor PBMCs into iPSCs via integration-free Sendai virus, confirmed donor STR identity, vector clearance, normal karyotype, pluripotency markers, and trilineage potential, then introduced the APP Swedish mutation by genome editing. Three validated APPswe clones retained NANOG/OCT4 expression. WT and APPswe clones differentiated into cortical neurons expressing NeuN and MAP2, with voltage-gated Na⁺/K⁺ currents, evoked and spontaneous action potentials, and high TfR and CD98 expression. APPswe neurons showed significantly elevated Aβ42, Aβ40, total Aβ, phospho-tau217, and phospho-tau181 versus isogenic controls.

Key Insights

An isogenic APP Swedish iPSC-derived cortical neuron model, built on a fully characterized healthy-donor background, reproduces hallmark amyloid and phospho-tau phenotypes of familial Alzheimer’s disease against matched wild-type controls.
  • Genetic background controlled by design. The APPswe mutation was edited directly into a validated healthy-donor iPSC line, so parental WT cells serve as matched isogenic controls and phenotype differences cannot be attributed to donor-to-donor variability.
  • Functional neurons, not just marker-positive cells. Differentiated cultures from both genotypes expressed NeuN and MAP2 and showed voltage-gated Na⁺/K⁺ currents, evoked action potentials, and spontaneous firing by patch clamp, alongside high TfR and CD98 expression relevant to BBB shuttle studies.
  • Clear, multi-biomarker AD phenotype. APPswe neurons showed roughly 3-fold higher Aβ42, 5-fold higher Aβ40 and total Aβ, 2.5-fold higher phospho-tau217, and 8-fold higher phospho-tau181 than isogenic WT controls (n = 3 per group).
Unlock Advanced Research Insights with Cyagen’s Resources
Explore an array of valuable resources tailored to enhance your preclinical research. Download mateirals meticulously crafted to provide advanced insights and methodologies. Elevate your research strategies with Cyagen's expertise.
Download Details
Full Name
Email
Organization
Job Role
Country
Main Area of Research
Resource Preferences
Which type of solutions are you considering?
Do you plan to start a project with us within the next 6 months?
How did you hear about us?
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCompany OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2026 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research